August 2023

Rheumatic diseasesBelimumab (Lympho-Stat-B, Benlysta GlaxoSmithKline Plc, London, United kingdom), a monoclonal antibodyRheumatic diseasesBelimumab (Lympho-Stat-B, Benlysta GlaxoSmithKline Plc, London, Uk), a monoclonal antibody against BAFF, has recently been accredited for your…